Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Ipsen    IPN   FR0010259150

IPSEN

(IPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about IPSEN
04/03MERRIMACK PHARMACEUTICALS : Divests Early Stage Asset for $2.25 Million, Provide..
AQ
04/02IPSEN : donates EUR2 million to the Institut Pasteur to support research on COVI..
AQ
04/01IPSEN : Donates €2 Million to the Institut Pasteur to Support Research on COVID-..
BU
03/26Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations..
AQ
03/26IPSEN : Provides Update on Palovarotene Clinical Programs
BU
03/25IPSEN : Provides COVID-19 Update
BU
03/11IPSEN : Multi-National PRESTO Study Presented by ENETS with Simultaneous Publica..
BU
03/11IPSEN : Data Presented during ENETS Annual Conference 2020 Capture New Patient a..
BU
03/10International companies to host live webcasts at Deutsche Bank's Depositary R..
AQ
02/14IPSEN : presents its 2019 results, provides 2020 guidance and updates 2022 finan..
AQ
02/13IPSEN :  Ipsen Presents Its 2019 Results, Provides 2020 Guidance and Updates 202..
BU
01/27IPSEN : palovarotene clinical program in fibrodysplasia ossificans progressiva r..
AQ
01/24EUROPE : European shares jump as positive PMI paints rosier picture
RE
01/24IPSEN : 's palovarotene clinical program in fibrodysplasia ossificans progressiv..
BU
01/17IPSEN : Half-year Statement of IPSEN Liquidity Agreement With NATIXIS ODDO BHF
BU
01/14IPSEN : Appoints Steven Hildemann, MD., PhD as Executive Vice President, Chief M..
BU
01/06IPSEN : Dysport now approved in the UK for symptomatic treatment of upper limb s..
AQ
01/06IPSEN : Dysport® (clostridium botulinum type A toxin-haemagglutinin complex) now..
BU
2019IPSEN : Announces Its Corporate Agenda For 2020
BU
2019IPSEN : CEO resigns, to join Ferring unit
RE
2019IPSEN : Announces Departure of David Meek as Chief Executive Officer
BU
2019ALERT : New purchases in the MarketScreener European Portfolio
2019IPSEN : Initiates Partial Clinical Hold for Palovarotene IND120181 and IND135403..
AQ
2019Health Care Lags Broad Market After Jobs Report -- Health Care Roundup
DJ
2019EUROPE : Strong U.S. jobs numbers, trade optimism bolster European shares
RE
2019MERRIMACK PHARMACEUTICALS : Receives $5 Million Milestone Payment from Ipsen Dec..
AQ
2019IPSEN : and Blueprint Medicines announce exclusive global license agreement to d..
AQ
2019IPSEN : announces positive results from Phase IIIb/IV ENGAGE study of the combin..
AQ
2019IPSEN : to present new data at 13th Annual Conference of the International Liver..
AQ
2019IPSEN : and Servier announce initial Phase II/III clinical data evaluating inves..
AQ
2019IPSEN : and Servier announce initial Phase II/III clinical data evaluating inves..
AQ
2019IPSEN : Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer
AQ
2019IPSEN : Debiopharm and Ipsen extend their strategic Decapeptyl partnership for a..
AQ
2019IPSEN : Ex-dividend day for final dividend
FA
2019MARKET SNAPSHOT: Stocks Close Higher As Trump Delays China Tariff Deadline
DJ
2019EUROPE : Trade tariff reprieve triggers relief in European shares
RE
2019GLOBAL MARKETS LIVE : Roche, AT&T, Spotify, General Electric…
2019Ipsen to buy Clementia Pharmaceuticals in deal worth up to $1.3 billion
RE
2019GLOBAL MARKETS LIVE : Google, Airbus, Volkswagen, Cisco…
2019EUROPE : Big losses for European stocks as Caterpillar, China disappoint
RE
2019IPSEN : commits to making all its published scientific research freely accessibl..
PU
2019IPSEN : Patients living with spasticity want long-lasting symptom relief
PU
2019IPSEN : announces 50 posters to be presented at the 2019 TOXINS Congress –..
PU
2019IPSEN : a story of transformation and growth
PU
2018IPSEN : Season's Greetings
PU
2018IPSEN : France signs milestone Cancer and Employment Charter at French Cancer Na..
PU
2018IPSEN : French pharma group Ipsen closes in on its next drug deals
RE
2018IPSEN : inaugurates new office in Singapore
PU
2018IPSEN : delivers strong sales growth of 20.2% for the third quarter of 2018 and ..
PU
2018IPSEN : “How France can leverage its attributes and deliver on its full po..
PU
2018IPSEN : How Ipsen is waging war on cancer by Bartek BEDNARZ
PU
2018SPREAD THE WORD : it is Liver Cancer Awareness Month
PU
2018IPSEN : Q3 2018 Sales Conference Call – Thursday, October 25
PU
2018IPSEN : appoints Dr. Yan Moore as Senior Vice President, Head of Oncology Therap..
PU
2018IPSEN : relocating German affiliate to Munich
PU
2018IPSEN : delivers strong results for the first half of 2018 with sales growth of ..
PU
2018IPSEN : Half Year 2018 Results Conference Call – Thursday, July 26
PU
2018IPSEN : Aujourd'hui, c'est la journée mondiale des questions-réponses sur le can..
PU
2018IPSEN : Today is World Kidney Cancer Q&A Day!
PU
2018IPSEN : Ex-dividend day for final dividend
FA
2018IPSEN : Boston and Paris – two rich ecosystems of R&D excellence
PU
2018IPSEN : at ASCO 2018
PU
2018IPSEN : European Commission approves Ipsen's Cabometyx® (cabozantinib) for the f..
PU
2018IPSEN : Neuroendocrine Tumor (NET) Expert Call
PU
2018European shares build on recovery, Airbus shines
RE
2018French pharma group Ipsen sees more asset purchases, U.S. growth
RE
2018IPSEN : International Childhood Cancer Day, Ipsen mobilizes its teams
PU
2018IPSEN : delivers strong 2017 results with 21.1% sales growth and..
PU
2018IPSEN : Full Year 2017 Financial Results
PU
2018IPSEN : Dr Sotirios G. Stergiopoulos appointed as Ipsen Chief Medical Officer
PU
2018IPSEN : at ASCO GI 2018
PU
2018IPSEN : and Exelixis to host joint investor briefing on Phase 3 CELESTIAL trial ..
PU
2018IPSEN TO PRESENT AT THE J.P. MORGAN : 00 am PST
PU
2017IPSEN : announces its corporate agenda for 2018
PU
2017IPSEN : shows a strong sales growth of 22.6 in Q3 2017
PU
1  2  3  4  5  6Next
Upcoming event on IPSEN